181. Evaluation of a Pilot Initiative for Tracking and Monitoring Indications Associated with Antibiotic Orders
Session: Poster Abstract Session: Antimicrobial Stewardship: Interventions Leveraging the Electronic Health Record
Thursday, October 4, 2018
Room: S Poster Hall
Posters
  • Jamie John IDWeek Poster 2018 Antibiotic Indication V5.pdf (644.4 kB)
  • Background:

    The Christiana Care Antimicrobial Stewardship Program developed a pilot initiative for tracking and monitoring antibiotic utilization across the health system. This initiative aligns with the Joint Commission’s elements of performance, which calls for tracking and reporting of antibiotic prescribing, as well as the Centers for Medicare and Medicaid Services recommendations for documentation of antibiotic indication, dose, and duration with each order. A customized indication list in the order entry field was created for cefepime, ceftriaxone, levofloxacin, and ciprofloxacin orders.

    Methods:

    A retrospective chart review of antibiotic indications was completed. A maximum of 50 orders per each antibiotic from December 31st, 2017 to January 6, 2018 were randomly selected to be evaluated. The primary endpoint of our study was the percent of cases in which the indication was selected according to the true indication per chart review. Secondary endpoints included the percent of cases in which “other indication” was selected where an available indication was appropriate, percent of cases in which the appropriate dose and frequency were prescribed, and percent of cases in which the duration of therapy was appropriate for urinary tract infections (UTIs).

    Results:

    A total of 540 orders were profiled between December 31st, 2017 and January 6, 2018, of which 182 were reviewed. In regards to accuracy of selected indication, 94% of cefepime, 88% of ceftriaxone, 78% of ciprofloxacin, and 89% of levofloxacin orders were considered appropriate. Dosing was most appropriate among ciprofloxacin orders (100%), followed by ceftriaxone (96%), cefepime (94%), and levofloxacin (74%). Frequency was most appropriate among ceftriaxone orders (98%), followed by ciprofloxacin (87%), levofloxacin (78%), and cefepime (74%). Duration of therapy was appropriate in greater than 90% of UTI orders.

    Conclusion:

    The pilot initiative for tracking and monitoring of antibiotic indications has allowed for enhanced transparency between providers regarding antimicrobial use. Further evaluation may provide greater understanding of antibiotic utilization and aid in identifying opportunities for improvements.

    Jamie John, PharmD1, Nicole Harrington, PharmD, BCPS1, Julianne Gardner, PharmD1, Jillian Dougherty, PharmD, BCPS1, Donna Walsh, PharmD1, Erin Dzuriak, PharmD1, Marci Drees, MD, MS1, Stephen Eppes, MD2, Sharath Kharidi, MD1 and Linda Cheung, PharmD Candidate1, (1)Christiana Care Health System, Newark, DE, (2)Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA

    Disclosures:

    J. John, None

    N. Harrington, None

    J. Gardner, None

    J. Dougherty, None

    D. Walsh, None

    E. Dzuriak, None

    M. Drees, None

    S. Eppes, None

    S. Kharidi, None

    L. Cheung, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.